Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary? : Two case reports and literature review.

van Kruijsdijk RCM, Abrahams AC, Nguyen TQ, Minnema MC, Jacobs JFM, Limper M.

J Nephrol. 2020 Mar 27. doi: 10.1007/s40620-020-00723-2. [Epub ahead of print]

PMID:
32221859
2.

Choosing the right strategy based on individualized treatment effect predictions: combination versus sequential chemotherapy in patients with metastatic colorectal cancer.

Kwakman JJM, van Kruijsdijk RCM, Elias SG, Seymour MT, Meade AM, Visseren FLJ, Punt CJA, Koopman M.

Acta Oncol. 2019 Mar;58(3):326-333. doi: 10.1080/0284186X.2018.1564840. Epub 2019 Jan 18.

3.

Central nervous system localisation of chronic lymphocytic leukaemia, description of two very distinct cases and a review of the literature.

Timmers NKLM, de Maar JS, van Kruijsdijk RCM, Klein SK.

Ann Hematol. 2018 Sep;97(9):1627-1632. doi: 10.1007/s00277-018-3329-2. Epub 2018 Apr 29. Review.

4.

The Effects of Secondary Cardiovascular Prevention on Cancer Risk in Patients With Manifest Vascular Disease.

van Kruijsdijk RC, van der Graaf Y, Algra A, de Borst GJ, Cramer MJ, Siersema PD, Peeters PH, Visseren FL; SMART study group.

J Am Coll Cardiol. 2016 Dec 13;68(23):2588-2589. doi: 10.1016/j.jacc.2016.09.950. No abstract available.

5.

Pemetrexed plus carboplatin versus pemetrexed in pretreated patients with advanced non-squamous non-small-cell lung cancer: treating the right patients based on individualized treatment effect prediction.

van Kruijsdijk RC, Visseren FL, Boni L, Groen HJ, Dingemans AM, Aerts JG, van der Graaf Y, Ardizzoni A, Smit EF.

Ann Oncol. 2016 Jul;27(7):1280-6. doi: 10.1093/annonc/mdw154. Epub 2016 Apr 6.

6.

How to translate clinical trial results into gain in healthy life expectancy for individual patients.

Dorresteijn JA, Kaasenbrood L, Cook NR, van Kruijsdijk RC, van der Graaf Y, Visseren FL, Ridker PM.

BMJ. 2016 Mar 30;352:i1548. doi: 10.1136/bmj.i1548. No abstract available.

PMID:
27029390
7.

Cause-specific mortality and years of life lost in patients with different manifestations of vascular disease.

van Kruijsdijk RC, van der Graaf Y, Koffijberg H, de Borst GJ, Nathoe HM, Jaap Kappelle L, Visseren FL; SMART study group.

Eur J Prev Cardiol. 2016 Jan;23(2):160-9. doi: 10.1177/2047487314566998. Epub 2015 Jan 16.

PMID:
25595551
8.

Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women.

van Kruijsdijk RC, Visseren FL, Ridker PM, Dorresteijn JA, Buring JE, van der Graaf Y, Cook NR.

Heart. 2015 Mar;101(5):369-76. doi: 10.1136/heartjnl-2014-306342. Epub 2014 Dec 4.

9.

The relation between resting heart rate and cancer incidence, cancer mortality and all-cause mortality in patients with manifest vascular disease.

van Kruijsdijk RC, van der Graaf Y, Bemelmans RH, Nathoe HM, Peeters PH, Visseren FL; SMART Study Group.

Cancer Epidemiol. 2014 Dec;38(6):715-21. doi: 10.1016/j.canep.2014.09.004. Epub 2014 Oct 17.

PMID:
25448083
10.

Cancer risk in patients with manifest vascular disease: effects of smoking, obesity, and metabolic syndrome.

van Kruijsdijk RC, van der Graaf Y, Peeters PH, Visseren FL; Second Manifestations of ARTerial disease (SMART) study group.

Cancer Epidemiol Biomarkers Prev. 2013 Jul;22(7):1267-77. doi: 10.1158/1055-9965.EPI-13-0090. Epub 2013 May 15.

11.

[Competing risks in clinical research].

van Kruijsdijk RC, Eijkemans MJ, Visseren FL.

Ned Tijdschr Geneeskd. 2012;156(46):A5176. Review. Dutch.

PMID:
23151330
12.

Sepsis-related myocardial calcification.

van Kruijsdijk RC, van der Heijden JJ, Uijlings R, Otterspoor LC.

Circ Heart Fail. 2011 Sep;4(5):e16-8. doi: 10.1161/CIRCHEARTFAILURE.111.962183. No abstract available.

PMID:
21934087
13.

Obesity and cancer: the role of dysfunctional adipose tissue.

van Kruijsdijk RC, van der Wall E, Visseren FL.

Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2569-78. doi: 10.1158/1055-9965.EPI-09-0372. Epub 2009 Sep 15. Review.

Supplemental Content

Loading ...
Support Center